Inhibrx Inc (INBX) Insider Trading
- $55,659,872.84
- $20,955,982.05
- Sept. 3, 2024
- Brendan P Eckelman
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 3, 2024 | CEO | 20,000 | $15.81 | Buy | $316,200.00 | |
| Aug. 29, 2024 | CEO | 10,000 | $14.03 | Buy | $140,300.00 | |
| June 5, 2024 | Director | 57,549 | $17.32 | Buy | $996,748.68 | |
| May 28, 2024 | Insider | 300,000 | $34.30 | Sell | $10,290,000.00 | |
| Aug. 28, 2023 | Major Shareholder | 511,627 | $19.35 | Buy | $9,899,982.45 | |
| Feb. 1, 2023 | Insider | 28,750 | $24.73 | Sell | $710,987.50 | |
| Jan. 23, 2023 | CEO | 21,665 | $25.36 | Sell | $549,424.40 | |
| Jan. 23, 2023 | Director | 9,500 | $25.26 | Sell | $239,970.00 | |
| Jan. 3, 2023 | Insider | 32,895 | $23.77 | Sell | $781,914.15 | |
| Dec. 21, 2022 | Director | 9,500 | $27.02 | Sell | $256,690.00 | |
| Dec. 19, 2022 | CEO | 26,000 | $25.56 | Sell | $664,560.00 | |
| Dec. 6, 2022 | Insider | 40,000 | $27.22 | Sell | $1,088,800.00 | |
| Nov. 21, 2022 | Director | 9,500 | $29.89 | Sell | $283,955.00 | |
| Nov. 1, 2022 | Insider | 40,000 | $33.51 | Sell | $1,340,400.00 | |
| Oct. 21, 2022 | Director | 9,500 | $30.13 | Sell | $286,235.00 | |
| Oct. 17, 2022 | CEO | 26,000 | $29.59 | Sell | $769,340.00 | |
| Oct. 7, 2022 | Major Shareholder | 1,333,333 | $30.00 | Buy | $39,999,990.00 | |
| Oct. 4, 2022 | Insider | 40,000 | $27.82 | Sell | $1,112,800.00 | |
| Aug. 2, 2022 | Insider | 24,500 | $17.70 | Sell | $433,650.00 | |
| July 7, 2022 | Chief Scientific Officer | 40,000 | $17.17 | Sell | $686,800.00 | |
| July 7, 2022 | Insider | 40,000 | $17.17 | Sell | $686,800.00 | |
| April 5, 2022 | Insider | 400 | $25.04 | Sell | $10,016.00 | |
| March 24, 2021 | Insider | 17,000 | $19.02 | Sell | $323,340.00 | |
| Feb. 16, 2021 | Insider | 17,000 | $25.90 | Sell | $440,300.00 | |
| Aug. 26, 2020 | Major Shareholder | 180,219 | $18.92 | Buy | $3,409,743.48 | |
| Aug. 24, 2020 | Major Shareholder | 46,161 | $19.43 | Buy | $896,908.23 |
Insiders are both buying and selling Inhibrx Inc stock.
The insider traders at Inhibrx Inc are: Brendan P Eckelman, Jon Faiz Kayyem, Mark Lappe, Global Investors Lp Viking, and Eckelman Brendan P.
The most active insider trader at Inhibrx Inc is Brendan P Eckelman with 11 trades.
Brendan P Eckelman has sold the most Inhibrx Inc stock with a total value of $27,509,007.65.
Global Investors Lp Viking has bought the most Inhibrx Inc stock with a total value of $64,106,606.61.
The most recent insider trade for Inhibrx Inc was on Sept. 3, 2024.
The single biggest insider buy for Inhibrx Inc was from Global Investors Lp Viking with a total value of $39,999,990.00 on Oct. 7, 2022.
The single biggest insider sell for Inhibrx Inc was from Brendan P Eckelman with a total value of $10,290,000.00 on May 28, 2024.